Bio-Rad Laboratories (BIO)

$320.06 -0.28 (-0.09%)
Market Cap 8.59B
Revenue (ttm) 2.57B
Net Income (ttm) -1.84B
EPS (ttm) N/A
PE Ratio 30.90
Forward PE 31.92
Profit Margin -71.86%
Debt to Equity Ratio 0.18
Volume 114,200
Avg Vol 216,284
Day's Range N/A - N/A
Shares Out 26.98M
Stochastic %K 61%
Beta 1.18
Analysts Sell
Price Target $341.25

Company Profile

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, q...

Industry: Medical Devices
Sector: Healthcare
Phone: 510 724 7000
Fax: 510 741 5817
Address:
1000 Alfred Nobel Drive, Hercules, United States
BillionerOfKing
BillionerOfKing Dec. 4 at 6:53 PM
$BIO Current Stock Price: $318.34 Contracts to trade: $320 BIO Dec 19 2025 Call Entry: $3.00 Exit: $5.75 ROI: 92% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 13 at 3:21 PM
$BIO Share Price: $325.39 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $12.75 – $15.75 Target Zone: $20.46 – $25.00 Potential Upside: 52% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 9:29 PM
$BG $BIDU $BIO $BK $BKCH
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 5 at 3:09 AM
$BIO Share Price: $311.51 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $8.50 – $10.50 Target Zone: $15.04 – $18.38 Potential Upside: 67% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 4 at 9:17 PM
$BKCH $BK $BIO $BIDU $BG 🔥
0 · Reply
MKRReformed
MKRReformed Oct. 21 at 4:46 PM
$ADVB great intraday move so far bro $BIO $NERV $VSEE
1 · Reply
SpartanVI
SpartanVI Oct. 21 at 2:57 PM
$ADVB $NERV $VSEE $BIO Advb had that look
0 · Reply
Paraboljoker
Paraboljoker Oct. 21 at 2:56 PM
$ADVB $.48 strong setup bio play bottom here IPO $4.X low float, bio's exploding of $NERV $VSEE $BIO
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 7:27 PM
Enter: $BIO NOV 21 2025 $320 CALLS Buy in Price: $9.75 - $15.00 Take Profit: $15.31 Stop Bleeding: $8.58 ROI Potential: 57% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Wigglyick
Wigglyick Oct. 16 at 8:38 PM
That sound you hear is the sucking chest wound in my acct…. But……some things working but not enough to matter, lol. $VEEV $BWXT $ANET $BIO had a good day, though I don’t own it yet
0 · Reply
Latest News on BIO
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

Oct 30, 2025, 5:17 PM EDT - 5 weeks ago

Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 7:56 PM EDT - 5 weeks ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript

Bio-Rad Reports Third-Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 5 weeks ago

Bio-Rad Reports Third-Quarter 2025 Financial Results

Compelling Value In Small-Cap Equities And Select Cyclicals

Oct 23, 2025, 11:45 PM EDT - 6 weeks ago

Compelling Value In Small-Cap Equities And Select Cyclicals

AJG B CLB FISV HON MOS REZI

7 Stocks Taking The Next Step To Be On Offense

Oct 23, 2025, 7:30 PM EDT - 6 weeks ago

7 Stocks Taking The Next Step To Be On Offense

ACI CNX FCF FDX FIS IAC KHC

It's time to scoop up undervalued stocks in this critical sector of the economy

Oct 21, 2025, 11:07 AM EDT - 6 weeks ago

It's time to scoop up undervalued stocks in this critical sector of the economy

BSX ISRG SYK BDX BDYN FEGE JGLO

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

Oct 16, 2025, 5:30 PM EDT - 7 weeks ago

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.

Sep 4, 2025, 5:19 PM EDT - 3 months ago

Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.

Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Sep 4, 2025, 5:07 PM EDT - 3 months ago

Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Bio-Rad's Management to Participate in Upcoming Investor Conferences

Aug 25, 2025, 9:00 AM EDT - 3 months ago

Bio-Rad's Management to Participate in Upcoming Investor Conferences

Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause

Aug 7, 2025, 7:30 AM EDT - 4 months ago

Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause

Bio-Rad (BIO) Q2 EPS Jumps 51%

Aug 1, 2025, 8:25 PM EDT - 4 months ago

Bio-Rad (BIO) Q2 EPS Jumps 51%

Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Aug 1, 2025, 11:30 AM EDT - 4 months ago

Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Aug 1, 2025, 9:00 AM EDT - 4 months ago

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:55 PM EDT - 4 months ago

Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript

Bio-Rad Reports Second-Quarter 2025 Financial Results

Jul 31, 2025, 4:15 PM EDT - 4 months ago

Bio-Rad Reports Second-Quarter 2025 Financial Results

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

Jul 28, 2025, 4:15 PM EDT - 4 months ago

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Jul 17, 2025, 4:15 PM EDT - 5 months ago

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

Jul 7, 2025, 9:00 AM EDT - 5 months ago

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

May 29, 2025, 4:30 PM EDT - 6 months ago

Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

May 12, 2025, 4:30 PM EDT - 7 months ago

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript

May 1, 2025, 10:35 PM EDT - 7 months ago

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript

Bio-Rad Reports First-Quarter 2025 Financial Results

May 1, 2025, 4:15 PM EDT - 7 months ago

Bio-Rad Reports First-Quarter 2025 Financial Results

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 11:45 PM EST - 10 months ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 4:20 PM EST - 10 months ago

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Feb 13, 2025, 4:15 PM EST - 10 months ago

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Jan 27, 2025, 5:00 PM EST - 11 months ago

Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Jan 8, 2025, 8:15 AM EST - 11 months ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

LH

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Jan 2, 2025, 4:30 PM EST - 1 year ago

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Nov 21, 2024, 9:00 AM EST - 1 year ago

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Oct 31, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 8:22 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Oct 30, 2024, 6:09 PM EDT - 1 year ago

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Bio-Rad Reports Third-Quarter 2024 Financial Results

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Third-Quarter 2024 Financial Results

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Oct 14, 2024, 5:30 PM EDT - 1 year ago

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Sep 6, 2024, 6:43 PM EDT - 1 year ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

ADNT CHCT CMP CNH DBI DDD DELL

Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference

Aug 22, 2024, 4:30 PM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Aug 20, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 10:47 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products

Aug 1, 2024, 5:56 PM EDT - 1 year ago

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products

Bio-Rad Reports Second-Quarter 2024 Financial Results

Aug 1, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Second-Quarter 2024 Financial Results

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Jul 17, 2024, 4:30 PM EDT - 1 year ago

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

May 30, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

May 23, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:16 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip

May 7, 2024, 6:11 PM EDT - 1 year ago

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip

Bio-Rad Reports First-Quarter 2024 Financial Results

May 7, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports First-Quarter 2024 Financial Results

Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

May 1, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

Bio-Rad Announces Life Science Group Management Changes

Apr 26, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Announces Life Science Group Management Changes

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Apr 18, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

BillionerOfKing
BillionerOfKing Dec. 4 at 6:53 PM
$BIO Current Stock Price: $318.34 Contracts to trade: $320 BIO Dec 19 2025 Call Entry: $3.00 Exit: $5.75 ROI: 92% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 13 at 3:21 PM
$BIO Share Price: $325.39 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $12.75 – $15.75 Target Zone: $20.46 – $25.00 Potential Upside: 52% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 9:29 PM
$BG $BIDU $BIO $BK $BKCH
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 5 at 3:09 AM
$BIO Share Price: $311.51 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $8.50 – $10.50 Target Zone: $15.04 – $18.38 Potential Upside: 67% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 4 at 9:17 PM
$BKCH $BK $BIO $BIDU $BG 🔥
0 · Reply
MKRReformed
MKRReformed Oct. 21 at 4:46 PM
$ADVB great intraday move so far bro $BIO $NERV $VSEE
1 · Reply
SpartanVI
SpartanVI Oct. 21 at 2:57 PM
$ADVB $NERV $VSEE $BIO Advb had that look
0 · Reply
Paraboljoker
Paraboljoker Oct. 21 at 2:56 PM
$ADVB $.48 strong setup bio play bottom here IPO $4.X low float, bio's exploding of $NERV $VSEE $BIO
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 7:27 PM
Enter: $BIO NOV 21 2025 $320 CALLS Buy in Price: $9.75 - $15.00 Take Profit: $15.31 Stop Bleeding: $8.58 ROI Potential: 57% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Wigglyick
Wigglyick Oct. 16 at 8:38 PM
That sound you hear is the sucking chest wound in my acct…. But……some things working but not enough to matter, lol. $VEEV $BWXT $ANET $BIO had a good day, though I don’t own it yet
0 · Reply
Wigglyick
Wigglyick Oct. 16 at 1:46 PM
$BIO highlighted BioRad 10 days ago, breaking out. ER coming up end of month. Good luck
0 · Reply
Invest2live
Invest2live Oct. 15 at 8:20 PM
$GNPX 247% already; congrats 🎈 🎊🎉 Check out $BIO Check out $IBIO and $ rxrx
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 7:26 PM
RBC Capital has updated their rating for Bio-Rad Laboratories ( $BIO ) to Outperform with a price target of 447.
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 7:24 PM
RBC Capital has adjusted their stance on Bio-Rad Laboratories ( $BIO ), setting the rating to Outperform with a target price of 430 → 409.
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 7:22 PM
Citigroup updates rating for Bio-Rad Laboratories ( $BIO ) to Buy, target set at 450 → 400.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 4:52 PM
Results of list 9/26/25 $BIIB $BIO $BIPC $BIRK 🔥 Cycle Trading Signal plugged into AI 🔥 list 🔥
0 · Reply
Wigglyick
Wigglyick Oct. 5 at 9:20 PM
$BIO BioRad looks like it’s trying to get back to the 370-400 range. Just had a gold cross on the daily and a MACD cross.
0 · Reply
SuperGreenToday
SuperGreenToday Sep. 30 at 1:42 AM
$BIO Share Price: $270.12 Contract Selected: Mar 20, 2026 $260 Calls Buy Zone: $25.84 – $31.92 Target Zone: $47.92 – $58.57 Potential Upside: 75% ROI Time to Expiration: 171 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 8:32 AM
Enter: $BIO OCT 17 2025 $280 CALLS Buy in Price: $11.20 - $12.00 Take Profit: $16.69 Stop Bleeding: $9.86 ROI Potential: 49% Exit Within: 166 Minutes https://moneygroup.us/alerts
0 · Reply